In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Immune Response licenses Hybridon's 2nd-generation CpG DNA adjuvant
Immune Response Corporation not to proceed with HIV study
Immune Response announces restructuring of license agreement
The Immune Response Corporation announces payment from Agouron Pharmaceuticals
Nabi receives patents on Staphylococcus Epidermidis vaccine and immune globulin
Hollis-Eden licenses patents from Pharmadigm
Immune Response reaches agreement with Maryland Biotech Institute